Related Experiment Video
Updated: Dec 23, 2025
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.5K
An overview on medication-assisted treatment (MAT) for opioid dependence
Tanay Maiti1, Saibal Das2, Anand Ramasamy3
1Department of Psychiatry, All India Institute of Medical Sciences, Bhubaneswar, India.
Journal of Opioid Management
|April 25, 2020
Summary
Medication-assisted treatment (MAT) for opioid dependence offers significant benefits using drugs like buprenorphine, methadone, and naltrexone. This overview covers drug comparisons, clinical practices, and emerging treatment modalities for opioid use disorder.
Area of Science:
- Pharmacology
- Addiction Medicine
- Public Health
Background:
- Opioid dependence is a significant public health challenge.
- Medication-assisted treatment (MAT) is a cornerstone of effective opioid use disorder management.
- Various pharmacological options exist, each with unique profiles and applications.
Purpose of the Study:
- To provide a comprehensive overview of medication-assisted treatment (MAT) for opioid dependence.
- To highlight the benefits and therapeutic aspects of commonly used MAT medications.
- To discuss practical considerations for implementing MAT in diverse clinical settings.
Main Methods:
- Literature review and synthesis of current evidence on MAT.
- Comparison of pharmacological profiles, efficacy, and safety of buprenorphine, methadone, and naltrexone.
- Discussion of clinical practice guidelines and special population considerations.
Main Results:
- Buprenorphine, methadone, and naltrexone demonstrate significant efficacy in treating opioid dependence.
- MAT regimens vary in their pharmacological profiles, interactions, and safety considerations across populations.
- Cost-effectiveness and community-based approaches enhance MAT accessibility and outcomes.
Conclusions:
- MAT is a highly effective strategy for managing opioid dependence, with multiple evidence-based medication options.
- Tailoring treatment to individual patient needs and considering special populations are crucial for successful outcomes.
- Future directions include exploring novel treatment modalities and optimizing community-based MAT delivery.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10.1K
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.6K
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
814
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
814
01:15Drug Abuse and Addiction: Pharmacological Phenomena
1.0K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:22Opioid Receptors: Overview
3.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.7K
01:17Drug Dependence
1.5K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.5K
01:28Drug Therapy
197
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
197